PMC:7781500 / 17287-17464
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 211 | 38-48 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 214 | 78-96 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 215 | 160-168 | Disease | denotes | COVID-19 | MESH:C000657245 |
TEST0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 33409060-170-176-2361961 | 170-172 | ["32294495"] | denotes | 13 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T188 | 0-177 | Sentence | denotes | With its in-vitro effectivity against SARS-CoV-2 and good lung concentration, hydroxychloroquine is a drug candidate selected to be used as prophylaxis against COVID-19 [13-15]. |